
This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.

This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.

This article reports a unique statewide initiative in Minnesota to improve orders for high-tech diagnostic imaging tests while reducing their overall frequency and costs.

This framework suggests new meaningful use measures and guidance for prioritizing implementation of different health information technology functionalities, based on their expected financial effects.

Patients who often change medical groups have the highest healthcare costs. The improved coordination of an accountable care organization may reduce those costs.


This content is brought to you by Amgen This video summarizes the complex process of creating biologics from start to finish and describes some of the unique challenges-- and tremendous effort-- involved in delivering safe and effective biologics.






Implementation of a point-of-care case management team consisting of a nurse, social worker, pharmacist, and health navigators reduced readmissions and associated costs.

Academic detailing coupled with a provider survey did not decrease the rate of new prescriptions for costly, on-patent second-generation antipsychotics in a VA hospital.


Standardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.











259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
